Bioharvest Sciences Inc.
BHST Nasdaq
SEC CIK 1723464
Follow Bioharvest Sciences
Weekly email: filings, results
EPS, diluted
-
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $34.5M | −$11.1M |
| FY24 | $25.2M | −$12.9M |
| FY23 | $12.7M | −$12.6M |
| FY22 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 59.3% | −16.2% | −32.3% |
| FY24 | 55.4% | −27.7% | −51.3% |
| FY23 | 44.5% | −78.6% | −99.1% |
| FY22 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$9.6M |
| FY24 | −$9.5M |
| FY23 | −$10M |
| FY22 | - |
- Bioharvest Sciences
- Healthcare median
Show the numbers
| Year | Bioharvest Sciences | Healthcare median |
|---|---|---|
| FY25 | −32.3% | −30.6% |
| FY24 | −51.3% | −47% |
| FY23 | −99.1% | −58% |
| FY22 | - | −80.4% |